#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fontan procedure Adenomatous polyposis coli Acute myeloid leukaemia refractory HER2 gene amplification Ovarian cancer Solitary fibrous tumour ROHHAD syndrome Extranodal marginal zone B-cell lymphoma (MALT type) Congenital pseudarthrosis Glomerulonephritis chronic Congenital absence of bile ducts Neurofibromatosis Obesity Paroxysmal nocturnal haemoglobinuria Gastrointestinal disorder More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia – Life with Disease Alexander disease – Life with Disease Turner’s syndrome – Basic Information KBG syndrome Pemphigus – Life with Disease Nodal marginal zone B-cell lymphoma – Diagnostics Mast cell activation syndrome – Diagnostics Sarcoma – Life with Disease SAPHO syndrome – Treatment Angiosarcoma non-metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pantoprazole ZALFERMIN Golcadomide Esketamine Hydrochloride Dacomitinib Simeticone Tamuzimod Acetate Mosliciguat Rizolipase 534 TTX-381 Abbv-668 Nemvaleukin Alfa Aflibercept Diazepam Tafasitamab ABY-271 Iptacopan Goserelin Telitacicept More therapies…

    Learn about Your Condition

    Sepsis Prodromal Alzheimer's disease Hypochromic anaemia Abdominal infection Renal transplant Bacterial vaginosis Optic atrophy Anxiety Muscle strain Hyperkalaemia Cerebellar ataxia Immunodeficiency Hyperadrenocorticism Acute leukaemia Malignant oligodendroglioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of individualized doses of botulinum toxin type A (incobotulinumtoxin) in adults with severe spasticity caused by brain damage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Spain

  • Study on Bortezomib and Temozolomide for Patients with Recurrent Grade IV Glioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant glioma
    Investigated Drugs:
    • Bortezomib
    • Temozolomide
    Norway

  • Study on PBP1510 and Gemcitabine for Patients with Advanced Pancreatic Cancer After Previous Chemotherapy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Anti-(Pancreatic Adenocarcinoma Upregulated Factor) Igg1 Humanised Monoclonal Antibody
    Spain

  • Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaemia of chronic disease
    Investigated Drugs:
    • Darbepoetin Alfa
    • Efepoetin Alfa
    Bulgaria Czechia Italy Poland Romania Slovakia

  • Study on Improving Bone Health in Children with Cystic Fibrosis Using Cholecalciferol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Colecalciferol
    Czechia

  • Study on Changes in [18F]F-AraG Uptake After Radiotherapy in Patients with Non-Small Cell Lung Cancer, Melanoma, Breast Cancer, and Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    • Breast cancer
    • Malignant melanoma
    Investigated Drugs:
    • Nelarabine
    The Netherlands
Previous Page
1 … 388 389 390 391 392 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!